Cargando…
Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity
Antibody glycosylation is a key parameter in the optimization of antibody therapeutics. Here, we describe the production of the anti-cancer monoclonal antibody rituximab in the unicellular ciliate, Tetrahymena thermophila. The resulting antibody demonstrated enhanced antibody-dependent cell-mediated...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098438/ https://www.ncbi.nlm.nih.gov/pubmed/27594301 http://dx.doi.org/10.1080/19420862.2016.1228504 |